Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's Lab launches Bupropion Hydrochloride Extended-Release Tablets
>>
Dr. Reddy’s Lab soars on getting CRL from USFDA for NuvaRing, Copaxone
>>
Dr Reddy's falls after getting 8 observations from USFDA for its Duvvada facility
>>
Dr Reddy's gets 8 observations from USFDA for its Duvvada facility
>>
Dr. Reddy’s Lab soars on launching Vigabatrin Powder for Oral Solution
>>
Dr. Reddy’s Lab launches Vigabatrin Powder for Oral Solution
>>
Dr. Reddy’s Lab advances on launching Versavo in India
>>
Dr. Reddy’s Lab launches Versavo in India
>>
Dr. Reddy’s Lab get CRL from USFDA for NuvaRing, Copaxone
>>
USFDA completes audit at Dr. Reddy’s Laboratories’ Louisiana facility
<<
<
65
66
67
...145
>
>>